Beskrivelse

At the end of 2003, our EU-funded infrastructure project Oxnorm came to an end. It has contributed to the development of nomenclature, technology and basic research concerning the cellular phenotype at different oxygen tension levels. Funded by The European Commission?s 5th Framework Programme. (Peter Ebbesen,Vladimir Zachar,Trine Fink; Kai-Uwe Eckardt, Humboldt University, Germany; Max Gassmann, University of Zurich, Switzerland; Ian Stratford, Victoria University of Manchester, England; Thomas Kietzmann, Georg-August-Universität, Goettingen, Germany; M.O. de Landázuri, Hospital de la Princesa, Spain; Jorma Keski-Oja, University of Helsinki, Finland; Xavier Leverve, Joseph Fourier University, France; Erik Pettersen, University of Oslo, Norway; Lorenz Poellinger, Karolinska Institutet, Sweden; Patrick Maxwell, Imperial College of Science, Technology and Medicine, England; Ferenc Tóth, University Medical School, Hungary; Gerald Urban, Albert-Ludwigs-Universität Freiburg, Germany; Hans Will, Heinrich-Pette-Institut, Germany; Silvia Pastorekova, Slovak Academy of Sciences, Slovak Republic); ViVoX ApS, Denmark)
StatusAfsluttet
Effektiv start/slut dato31/12/200331/12/2003